Penalty Amount
$29,600,000
Attorney General William Tong led a coalition of 48 states and territories in a $29.6 million settlement with Glenmark, a generic drug manufacturer, to resolve allegations of a widespread conspiracy to artificially inflate prices, reduce competition, and unreasonably restrain trade for numerous generic prescription drugs. The settlement includes cooperation from Glenmark in ongoing multistate litigations and internal reforms to ensure fair competition and compliance with antitrust laws.
Glenmark must pay $29.6 million, cooperate in ongoing multistate litigations, and implement internal reforms to ensure fair competition and compliance with antitrust laws. Consumers who purchased certain generic prescription drugs between May 1, 2009 and December 31, 2019 may be eligible for compensation.
In-house legal teams should review vendor agreements with generic drug manufacturers for clauses related to pricing, market allocation, and competition. Specifically, contracts should include robust antitrust compliance provisions, prohibitions on price fixing and market division, and requirements for cooperation with regulatory investigations. Additionally, customer agreements with pharmacies and healthcare providers should be reviewed for any terms that could be construed as anti-competitive, such as exclusive dealing arrangements or resale price maintenance clauses. Employee agreements and training programs should also be updated to emphasize antitrust law compliance and reporting mechanisms for potential violations.
Entity
Glenmark
Industry
OtherOfficial Press Release
https://portal.ct.gov/ag/press-releases/2026-press-releases/attorney-general-tong-announces-settlement-with-glenmark-over-conspiracy-to-inflate-prices
states glenmark settlement agreement.pdf?rev=9f159e0ead02439
https://portal.ct.gov/-/media/ag/press_releases/2026/states-glenmark-settlement-agreement.pdf?rev=9f159e0ead02439c888fc06b366ed42b&hash=6086FA2E4C7567A135E6904D1722320E
Connecticut Attorney General Enforcement Page
https://portal.ct.gov/AG/Privacy/Privacy-Resources
"Glenmark"
"$29.6 million settlement with Glenmark"
"antitrust laws"
"conspired with manufacturers across the generic drug industry jack up prices and block competition for generic prescription drugs"
"coalition of 48 states and territories"
"internal reforms to ensure fair competition and compliance with antitrust laws"
$29.6M
Attorney General Jennifer Davenport joined a coalition of 48 states and territories in a $29.6 million settlement with Glenmark, a generic drug manufacturer, for allegedly conspiring to artificially inflate and manipulate prices, reduce competition, and restrain trade for numerous generic prescription drugs. The settlement includes cooperation in ongoing litigations and internal reforms to ensure fair competition.
Connecticut Attorney General William Tong joined a coalition of states and local governments in filing suit against NHTSA over its rule weakening fuel economy standards for new passenger cars and light trucks. The lawsuit alleges the rule violates the agency’s statutory mandate and the Administrative Procedure Act; no penalty or final remedy is reported.
Connecticut Attorney General William Tong joined a multistate coalition suing the EPA over its repeal of greenhouse gas pollution limits for power plants and separately filed a notice of intent to sue over regulation of existing gas plants. The coalition asks the court to overturn the repeal and restore the protections; the release reports no monetary penalty or final order.
$400.0M
Connecticut Attorney General William Tong announced a $400 million settlement with Sandoz Inc. and Fougera Pharmaceuticals Inc. resolving allegations that the generic drug manufacturers conspired to inflate prices, limit competition, and restrain trade. The settlement includes consumer restitution and injunctive reforms; court approval was being sought.
Connecticut Attorney General William Tong joined a coalition of 21 attorneys general in submitting a comment letter opposing a DHS rule that allows certain affirmative asylum applications to be referred to removal proceedings without an asylum officer interview. The coalition argues the rule violates federal law and harms asylum seekers, including unaccompanied children; this was a policy opposition letter, not a privacy enforcement action.
Connecticut and Massachusetts co-led a coalition protest urging FERC to reject the proposed NextEra Energy-Dominion Energy merger. The coalition argued that the merger could increase market power and threaten energy affordability, reliability, and competition; the release does not report a final enforcement decision or penalty.